Trigran reports 4.2% MiMedx ownership in 13G/A
MiMedx Group, Inc. has a new ownership update from Trigran-affiliated investors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MiMedx Group, Inc. has a new ownership update from Trigran-affiliated investors. An amended Schedule 13G shows Trigran Investments, Inc. and related individuals collectively reporting beneficial ownership of 6,163,384 shares of MiMedx common stock, representing 4.2% of the outstanding class as of the reported date.
The group reports no sole voting or dispositive power, with shared voting power over 5,688,192 shares and shared dispositive power over 6,163,384 shares. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MiMedx.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in MiMedx Group (MDXG) does Trigran report in this Schedule 13G/A?
Who are the reporting persons in the MiMedx (MDXG) Schedule 13G/A amendment?
Do the Trigran reporting persons seek control of MiMedx Group (MDXG)?
Why does the MiMedx (MDXG) Schedule 13G/A mention ownership of 5 percent or less?
AI-generated analysis. How Rhea-AI works. Not financial advice.